Tower Research Capital (TRC)’s MedEquities Realty Trust, Inc. MRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,860
Closed -$32K 4711
2019
Q1
$32K Buy
2,860
+2,619
+1,087% +$28.3K ﹤0.01% 2010
2018
Q4
$2K Buy
+241
New +$1.89K ﹤0.01% 3515
2018
Q3
Sell
-2,507
Closed -$28K 4542
2018
Q2
$28K Sell
2,507
-1,997
-44% -$20.6K ﹤0.01% 2225
2018
Q1
$47K Sell
4,504
-2,901
-39% -$30.8K ﹤0.01% 1714
2017
Q4
$83K Buy
7,405
+3,818
+106% +$43.3K 0.01% 990
2017
Q3
$42K Buy
+3,587
New +$42.5K ﹤0.01% 2131
2017
Q1
Sell
-1,449
Closed -$16K 4363
2016
Q4
$16K Buy
+1,449
New +$16.2K ﹤0.01% 2352

Tower Research Capital (TRC)'s MRT Position: Q2 2019 in Review

Tower Research Capital (TRC) sold out of MedEquities Realty Trust, Inc. (MRT) in Q2 2019, closing a stake of 2,860 shares — an estimated $32K sold.

Tower Research Capital (TRC) first reported a position in MRT in Q4 2016 and held it in 7 quarters. The position peaked at $83K in Q4 2017. 0 funds tracked by Wall St. Rank hold MRT as of Q2 2019.

  • Tower Research Capital (TRC) reported no remaining MedEquities Realty Trust, Inc. position as of Q2 2019 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,860 MedEquities Realty Trust, Inc. shares in Q2 2019, an estimated $32K.
  • Tower Research Capital (TRC) first reported a position in MedEquities Realty Trust, Inc. in Q4 2016 and held it in 7 quarters.
  • Tower Research Capital (TRC)'s MedEquities Realty Trust, Inc. position peaked at $83K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held MedEquities Realty Trust, Inc. as of Q2 2019.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.